ROCKLEDGE, Fla., January 2, 2018 /PRNewswire/ -- Elev8 Brands, Inc. (OTC Pink: VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee, tea, E-juices, CBD Lotions and CBD Tinctures that target the health and wellness markets, is pleased to  announce it has engaged the services of McMurdo Law Group, LLC to draft and file an S-1 Registration Statement with the Securities and Exchange Commission in an attempt to become a fully reporting company, and, eventually, move to the OTCQB.

As the Company continues to grow, upgrading to the OTCQB will provide a high level of transparency. OTCQB requires timely filing, full disclosures as well as audited financial statements that will create confidence and attract new investors.

Mr. Matthew McMurdo started his own firm in 2008. Prior to that, Mr. McMurdo was Of-Counsel at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., beginning in August 2007, where he specialized in securities transactions and private equity and venture transactions. From April 2006 until August 2007, Mr. McMurdo was an associate at Greenberg Traurig, LLP, where he specialized in securities transactions and merger and acquisition transactions. From November 2005 through April 2006, Mr. McMurdo was a corporate associate at Sullivan & Worcester LLP, where he practiced general corporate law and securities law. From September 2000 through November 2005, Mr. McMurdo was a corporate associate at Bingham McCutchen LLP, where he began his practice in securities law and further specialized in corporate governance and secured lending. Mr. McMurdo began practicing law in September 1998 at Brown & Wood LLP, in pooled investment entities associate focused on the 1940 Act. Mr. McMurdo earned his J.D. from Benjamin N. Cardozo School of Law, where he graduated cum laude in 1998. He received a B.S. in Finance from Lehigh University in 1995.

CEO, Ryan Medico Stated, “I am so excited for what our team has accomplished thus far. We want to continue to build shareholder value and confidence and we believe there is no better way than to file an S-1 Registration Statement. We are looking forward to an amazing 2018.”

About Elev8 Brands, Inc.:
Elev8 Brands, Inc. specializes in the development and marketing of products for the fitness and wellness markets.  The company is founded based on creating high-quality, sustainable, products for health-conscious consumers. 

About Elev8 Hemp LLC:
Elev8 Hemp LLC is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of hemp-based food, beverage, and health care products including hemp coffee and hemp tea.

About 02 Breathe LLC:
02 Breathe is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on their oxygen bar while bringing in an array of CBD products. O2 Breathe carries CBD tinctures, CBD vape, CBD lotions and massage products. 02 Breathe is currently looking to offer CBD at their oxygen bar.
Please visit, www.elev8hemp.com for more information. 
 
About Zoe CBD LLC:
Zoe CBD is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of CBD-based products such as CBD Tinctures, CBD E-Juice, CBD Lotion and CBD Salve.

www.facebook.com/elev8hemp 
www.instagram.com/elev8hemp 
www.twitter.com/elev8hemp 
www.02breathe.com
 
Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.